Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Stroke. 2017 May 9;48(6):1636–1645. doi: 10.1161/STROKEAHA.117.016650

Fig 3.

Fig 3

Post-stroke SAG (10mg/kg from post-stroke day 3–6) does not affect the proliferation of SVZ NSCs in stroke mice. (A) Experimental timeline and schematic diagram showing the dorsal and ventral SVZ regions. (B) Dorsal and ventral SVZ BrdU+ cells after vehicle or SAG treatment. (C) Dorsal and ventral SVZ PCNA+ cells after vehicle or SAG treatment. MEAN± SEM. *, p<0.05 contralateral side vs ipsilateral side, two-way ANOVA. No difference in vehicle vs SAG groups (n=7 each group).